What Omega Hospitals does

Omega Hospitals operates India's second-largest cancer-focused hospital chain, providing multidisciplinary oncology services — surgical, medical, radiation, hemato, neuro, and orthopaedic oncology — alongside complementary multi-specialty care. Headquartered in Hyderabad and founded in 2010 by Dr. Ch. Mohana Vamsy, Omega runs 9 hospitals with 1,000+ beds across 8+ Indian states, supported by advanced technology including the CyberKnife robotic radiosurgery system (exclusive in Telangana and Andhra Pradesh) and India's first Ethos LINAC AI-powered linear accelerator at its Gachibowli facility. The company has treated over 5.26 million patients cumulatively, performing 66,500+ surgeries, 3.78 lakh+ chemotherapy sessions, and 54,000+ radiation therapy sessions.

The business model is professional-services healthcare revenue: Omega bills patients directly, through insurance/TPA cashless arrangements, and via corporate empanelment with 50+ enterprises and government agencies. GTM combines direct-to-patient services at hospital locations, enterprise sales through corporate empanelment, and dedicated international patient (medical tourism) services with end-to-end support. The company is NABH-accredited, runs DNB/FNB oncology training programs across 7 locations, and maintains a digital presence through its website and consumer mobile app for appointment booking and engagement. Revenue is not publicly disclosed.

Following a ₹500 crore Morgan Stanley Private Equity Asia investment in June 2024 (23% stake, ~₹2,174 crore post-money valuation), Omega is in active expansion mode, having acquired a majority stake in Bangalore-based Cytecare Hospitals in November 2025 with an additional ~₹500 crore earmarked for quaternary cancer care development. The stated strategy is to scale from the #2 to #1 cancer care provider in India across Telangana, Andhra Pradesh, Tamil Nadu, Karnataka, Maharashtra, Madhya Pradesh, Uttarakhand, and West Bengal.

Name

Omega Hospitals

Legal name

Omega Hospitals

Website

https://omegahospitals.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Omega Hospitals is India's second-largest cancer-focused hospital chain, operating 9 hospitals with 1,000+ beds across 8+ states, providing surgical, medical, and radiation oncology alongside multi-specialty care to cancer patients, corporate clients, and international medical tourists.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223)

SIC

Services-Hospitals (8060), Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Cancer treatment services
• Oncology hospital services
• Radiation oncology
• Surgical oncology
• Multi-specialty healthcare

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices18 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Hospital Healthcare Services: Omega Hospitals generates revenue through providing comprehensive cancer care and multi-specialty healthcare services including consultations, diagnostic tests, treatments (chemotherapy, radiotherapy, surgeries), and inpatient/outpatient services. Revenue is earned through direct patient payments, insurance claims (cashless and reimbursement), and corporate empanelment agreements.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Omega Hospitals operates a network of specialized cancer care hospitals providing comprehensive multidisciplinary oncology services including surgical, medical, and radiation oncology. It delivers advanced treatments such as CyberKnife robotic radiosurgery, AI-powered Ethos LINAC adaptive radiotherapy, chemotherapy, immunotherapy, bone marrow transplant, and supporting multi-specialty, diagnostic, and consultation services to cancer patients across India.

Product overview

Omega Hospitals operates as India's second-largest cancer-focused hospital chain with a platform-plus-modules architecture. The core offering is comprehensive oncology services spanning Surgical Oncology, Medical Oncology, Radiation Oncology, Hemato Oncology and BMT, Neuro Oncology, Orthopaedic Oncology, Nuclear Medicine & PET-CT, and CyberKnife Robotic Radiosurgery. Supporting this core are multi-specialty services (cardiology, neurology, gastroenterology, etc.), diagnostic services (laboratory, radiology, pathology), doctor consultation (in-person and video), and patient accommodation facilities. The hospital chain has expanded through acquisitions (Cytecare Hospitals in 2025) and operates across 17+ locations in India including Hyderabad, Vizag, Guntur, Bangalore, and others, backed by Morgan Stanley Private Equity since 2024.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 5,26,300+ total lives touched
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Partnerships

One partnership is on record.

• Cytecare HospitalscoreStrategic or Co-development Partner · 5 November 2025Omega Hospitals acquired a majority stake in Cytecare Hospitals, a Bangalore-based oncology centre. The acquisition was backed by Morgan Stanley Private Equity with an investment of about ₹500 crore, aiming to develop Cytecare into Omega's centre of excellence for quaternary cancer care. This strategic acquisition expands Omega's oncology footprint in Karnataka.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• HealthCare Global Enterprises (HCG): India's largest dedicated cancer hospital chain, operating a multi-centre oncology network with surgical, medical and radiation oncology. Direct head-to-head competitor to Omega for cancer patients, oncologist talent, and regional expansion, especially in southern and western India.
• Cytecare Hospitals: Bangalore-based quaternary oncology centre now majority-owned by Omega following the November 2025 acquisition. Previously an independent competitor in Karnataka, now operates as Omega's centre of excellence for quaternary cancer care.

Broad incumbents

• Apollo Hospitals Enterprise: India's largest hospital chain with broad multi-specialty footprint and significant oncology programs across its flagship centres. Competes with Omega for complex cancer cases, especially in Hyderabad, Bangalore and Visakhapatnam, but as part of a much wider service portfolio rather than as a dedicated oncology specialist.
• Fortis Healthcare: Large multi-specialty hospital chain with established oncology departments. Provides similar surgical, medical and radiation oncology services from a broader platform, competing with Omega for insured and corporate empanelled cancer patients in metros.
• Max Healthcare Institute: North-India-focused multi-specialty chain with growing oncology programs and advanced radiation capabilities. Comparable to Omega in scope of cancer services but addresses a different geography and broader service mix.
• Manipal Hospitals (Manipal Health Enterprises): Pan-India multi-specialty hospital chain with growing oncology capability across Karnataka, Andhra Pradesh, Telangana and beyond. Overlaps with Omega's southern footprint and competes for the same tertiary referral base.
• Medanta (Global Health): Large North-Indian tertiary hospital chain with significant cancer programs including radiation oncology. Comparable to Omega on advanced technology and clinical reputation, but operates from a broader multi-specialty platform.
• Narayana Health: Pan-India multi-specialty chain, historically cardiac-focused, expanding into comprehensive oncology across multiple states. Comparable operating model of hub-and-spoke specialty care delivered at scale, though oncology is a more recent pillar for Narayana than for Omega.

Regional players

• Tata Memorial Hospital (TMC/ACTREC): Government-funded specialty cancer centre in Mumbai and a network of satellite centres, considered India's gold standard for cancer treatment. Sets the clinical benchmark and price floor that Omega competes against, though its capacity constraints and subsidy-driven pricing model limit direct commercial overlap.
• KIMS Hospitals (Krishna Institute of Medical Sciences): Hyderabad-headquartered multi-specialty hospital chain with growing oncology services across Telangana, Andhra Pradesh and other states. A direct regional competitor for both patients and specialist talent in Omega's home market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@dr.mohanavamsy
• Facebookfacebook.com/OmegaHospitalsOfficial
• LinkedInlinkedin.com/company/omega-hospitals-hyderabad
• Instagraminstagram.com/omega.hospitals
• Xx.com/omegahospitals1

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omega Hospitals